Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neutropenia 1Hematologic Neoplasms 1

Interventions

Filgrastim 9Cytarabine 7Etoposide 5Cefepime 4Peripheral Blood Stem Cell Transplantation 3Mitoxantrone 3Levofloxacin 3Idarubicin 3Daunorubicin 3Cyclosporine 3Ciprofloxacin 3Caspofungin 3pegfilgrastim 2liposomal amphotericin B 2Thioguanine 2Radiotherapy 2Methotrexate 2Meropenem 2Itraconazole 2Cyclophosphamide 2Ceftazidime 2Amsacrine 2Amoxicillin-Potassium Clavulanate Combination 2sargramostim 1posaconazole 1lintuzumab 1leridistim 1isavuconazole 1fludarabine phosphate 1flt3 ligand protein 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × eravacycline × Other hematologic neoplasm × Clear all
NCT05537896 2026-04-16

Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia

West Virginia University

Phase 2 Recruiting
55 enrolled
Other hematologic neoplasm

Neutropenia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡